跳至主要内容
临床试验/CTRI/2022/07/043860
CTRI/2022/07/043860已完成4 期

A post market clinical follows up prospective study to evaluate safety and performance of Preservative Free Eye Preparations (Preservative Free Eye Drops with Chamomile and Euphrasia extract).

Stericon Pharma Private Limited0 个研究点目标入组 144 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
144

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • At the time of screening and usage of the product all subjects must meet the following criteria for inclusion into the study and the subjects will receive the prescribed eye drops from the PI/CO-PI by a medical practitioner. The inclusion criteria for the subjects for this study are as follows:
  • -Subjects who experience irritation , Itchiness, discomfort of eyes due to the continuous use of computer/TV/exposed pollution/dry environment
  • -Subjects wearing contact lenses who experience dryness, Itchiness, discomfort of eyes due to the continuous use of computer/TV/exposed pollution/dry environment

排除标准

  • The below Subjects are excluded from the study:
  • -Subjects who are not willing to participate in the study
  • -Anyone with known allergic reaction to Preservative Free Eye Drops with Chamomile and Euphrasia extract
  • -Subjects with existing eye infection
  • -Subjects undergone recent (6 weeks) cataract surgery who are on other eye medications

研究者

相似试验